HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2019 | $51.8 M |
2020 | $52.8 M |
Total: | $105 M |
Period | Weight, tons. |
---|---|
2019 | 30 |
2020 | 2.98 |
Total: | 32.9 |
Group product | 2019 | 2020 | Ch. | ∑ (2019-2020) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | $9.5 M | $8.9 M | 6% | $18.3 M | 17.5% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $10.3 M | $5.6 M | 46% | $15.9 M | 15.2% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $32.1 M | $38.4 M | 20% | $70.4 M | 67.3% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $51.8 M | $52.8 M | $105 M |
№ | Country | ∑ (2019-2020) | Ratio |
---|---|---|---|
1 | Germany | $5.11 B | 20.6% |
2 | United States | $2.16 B | 8.7% |
3 | Italy | $1.8 B | 7.2% |
4 | Switzerland | $1.74 B | 7% |
5 | France | $1.57 B | 6.3% |
6 | Ireland | $1.45 B | 5.8% |
7 | India | $1.14 B | 4.6% |
8 | United Kingdom | $858 M | 3.5% |
9 | Slovenia | $716 M | 2.9% |
10 | Hungary | $705 M | 2.8% |
11 | Netherlands | $675 M | 2.7% |
12 | Austria | $659 M | 2.6% |
13 | Spain | $560 M | 2.3% |
14 | Belarus | $430 M | 1.7% |
15 | Puerto Rico | $414 M | 1.7% |
... | ... | ... | ... |
31 | Israel | $107 M | 0.4% |
32 | Bosnia and Herzegovina | $105 M | 0.4% |
33 | Singapore | $105 M | 0.4% |
34 | Serbia | $99 M | 0.4% |
35 | Kazakhstan | $84 M | 0.3% |
... | ... | ... | ... |
The total for all countries: | $24.9 B | 100% |
№ | Region | ∑ (2019-2020) | Ratio |
---|---|---|---|
1 | Moskva | $104 M | 99.8% |
2 | Nijegorodskaya oblast | $244 K | 0.2% |
3 | Sankt-Peterburg | $5.49 K | 0% |
By all regions: | $105 M | 100% |